SHELL ASSET MANAGEMENT CO - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.

Quarter-by-quarter ownership
SHELL ASSET MANAGEMENT CO ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$559
+7.1%
14,515
-0.6%
0.02%0.0%
Q1 2023$522
-9.7%
14,598
-0.3%
0.02%
-12.0%
Q4 2022$578
-99.9%
14,649
-15.8%
0.02%
+4.2%
Q3 2022$628,000
-6.3%
17,400
-21.0%
0.02%
+20.0%
Q2 2022$670,000
-0.4%
22,025
-0.0%
0.02%
+25.0%
Q1 2022$673,000
-14.9%
22,031
-13.0%
0.02%0.0%
Q4 2021$791,000
+105.5%
25,329
+0.7%
0.02%
+77.8%
Q3 2021$385,000
-21.3%
25,165
-4.1%
0.01%0.0%
Q2 2021$489,000
+10.1%
26,245
+5.8%
0.01%0.0%
Q1 2021$444,00024,8050.01%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 790,000$12,071,0003.53%
GREAT POINT PARTNERS LLC 700,000$10,696,0002.49%
COMMODORE CAPITAL LP 579,432$8,854,0002.33%
ACUTA CAPITAL PARTNERS, LLC 417,409$6,378,0002.25%
DAFNA Capital Management LLC 406,535$6,212,0001.65%
Tri Locum Partners LP 264,134$4,036,0001.60%
Parkman Healthcare Partners LLC 311,207$4,755,0001.20%
Ghost Tree Capital, LLC 250,000$3,820,0001.12%
Nan Fung Group Holdings Ltd 197,880$3,024,0000.97%
BVF INC/IL 1,571,778$24,017,0000.94%
View complete list of XENON PHARMACEUTICALS INC shareholders